Dr. Sharma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5885 Landerbrook Dr
Ste 150
Cleveland, OH 44124Phone+1 216-767-8793Fax+1 216-767-8778
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2010 - 2011- University at BuffaloFellowship, Hematology and Medical Oncology, 2008 - 2010
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2005 - 2008
G.S.V.M Medical College KanpurClass of 2003
Certifications & Licensure
OH State Medical License 2011 - 2024
VA State Medical License 2023 - 2024
NY State Medical License 2010 - 2012
Clinical Trials
- Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors Start of enrollment: 2012 May 01
- Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer Start of enrollment: 2013 Sep 01
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
Publications & Presentations
PubMed
- 958 citationsSTK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma.Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Matthew D. Hellmann, Mark M. Awad
Cancer Discovery. 2018-05-17 - 339 citationsNCCN Guidelines ® Insights: Non-Small Cell Lung Cancer, Version 4.2016 Featured Updates to the NCCN GuidelinesDavid S. Ettinger, Douglas E. Wood, Wallace Akerley, Lyudmila Bazhenova, Hossein Borghaei
Journal of the National Comprehensive Cancer Network. 2016-03-01 - 11 citationsRadiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine.Nancy L. Oleinick, Tithi Biswas, R. Patel, Mingfang Tao, Ravi Patel
Radiotherapy and Oncology. 2016-11-01
Press Mentions
Adopt Dairy Farming with Focus on Value Addition of Milk: SKUAST-VCJuly 11th, 2020
SKUAST-J Celebrates World Food DayOctober 16th, 2017
In the Clinic: Ongoing Clinical Trials Evaluating C-MET-Inhibiting DrugsNovember 1st, 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
